The COVID-19 pandemic has turned the world upside down. Heller researchers and alumni have stepped up.
Friends, coworkers and families are separated by shelter-in-place orders. Inequities in income, housing, education, and more are widening each day. Healthcare systems are straining to cope with the surge in new patients.
Members of the Heller community are hard at work, combating the pandemic as entrepreneurs, medical professionals and local and global public health leaders, as well as envisioning and advocating for the critical policy changes needed during this new reality.

What will it take to make COVID-19 vaccines globally available?
Global health expert A.K. Nandakumar on the challenges of obtaining and distributing two billion doses of a COVID-19 vaccine in low and middle-income countries by 2021.